• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

甲氨蝶呤、卡介苗和异烟肼联合治疗头颈部鳞状细胞癌的对照研究。

A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.

作者信息

Woods J E, DeSanto L W, Ritts R E

出版信息

Surg Clin North Am. 1977 Aug;57(4):769-78. doi: 10.1016/s0039-6109(16)41287-9.

DOI:10.1016/s0039-6109(16)41287-9
PMID:897965
Abstract

In a randomized prospective study of patients with advanced squamous cell carcinoma of the head and neck, treatment with MTX plus BCG and with MTX plus BCG plus INH produced no better response rate or survival time than treatment with MTX alone.

摘要

在一项针对晚期头颈部鳞状细胞癌患者的随机前瞻性研究中，与单独使用甲氨蝶呤治疗相比，甲氨蝶呤联合卡介苗以及甲氨蝶呤联合卡介苗加异烟肼治疗的缓解率和生存时间并无改善。

相似文献

1
A controlled study of combined methotrexate, BCG, and INH therapy for squamous cell carcinoma of the head and neck.甲氨蝶呤、卡介苗和异烟肼联合治疗头颈部鳞状细胞癌的对照研究。
Surg Clin North Am. 1977 Aug;57(4):769-78. doi: 10.1016/s0039-6109(16)41287-9.
2
Methotrexate plus Bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck.甲氨蝶呤联合卡介苗（BCG）及异烟肼治疗头颈部癌
Am J Surg. 1972 Oct;124(4):527-34. doi: 10.1016/0002-9610(72)90080-3.
3
T-cell rosette test in squamous cell carcinoma of the head and neck.头颈部鳞状细胞癌的T细胞玫瑰花结试验
Arch Otolaryngol. 1976 Mar;102(3):171-5. doi: 10.1001/archotol.1976.00780080093013.
4
Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck.甲氨蝶呤辅助治疗在头颈部晚期肿瘤放疗管理中的应用
Cancer. 1976 Jun;37(6):2703-8. doi: 10.1002/1097-0142(197606)37:6<2703::aid-cncr2820370620>3.0.co;2-h.
5
T-lymphocytes and survival of head and neck squamous cell carcinoma.T淋巴细胞与头颈部鳞状细胞癌的生存情况
Arch Otolaryngol. 1977 Apr;103(4):223-7. doi: 10.1001/archotol.1977.00780210079009.
6
Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.100例头颈部表皮样癌患者的卡介苗辅助免疫治疗结果
Am J Surg. 1977 Oct;134(4):474-8. doi: 10.1016/0002-9610(77)90381-6.
7
Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.卡巴他赛对比甲氨蝶呤用于铂类治疗后的复发性和/或转移性头颈部鳞状细胞癌患者的随机II期研究
Oncologist. 2016 Dec;21(12):1416-e17. doi: 10.1634/theoncologist.2016-0296. Epub 2016 Nov 30.
8
Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.甲氨蝶呤联合5-氟尿嘧啶序贯一小时给药与同步给药用于晚期和复发性头颈部鳞状细胞癌的前瞻性随机试验。
J Clin Oncol. 1983 Dec;1(12):787-92. doi: 10.1200/JCO.1983.1.12.787.
9
Therapy of recurrent squamous cell carcinoma of the head and neck using combination vincristine, bleomycin, and methotrexate. A Southwest Oncology Group Study.
Cancer. 1986 Dec 1;58(11):2382-5. doi: 10.1002/1097-0142(19861201)58:11<2382::aid-cncr2820581104>3.0.co;2-v.
10
Chemotherapy of head and neck cancer: combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin.
Med Pediatr Oncol. 1977;3(3):301-9. doi: 10.1002/mpo.2950030312.

引用本文的文献

1
Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.治疗口腔和口咽癌的干预措施：化疗。
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD006386. doi: 10.1002/14651858.CD006386.pub4.
2
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.口腔和口咽癌的治疗干预措施：靶向治疗和免疫治疗。
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010341. doi: 10.1002/14651858.CD010341.pub2.